Measuring 25-hydroxyvitamin D (25-OH) during menopause can be useful because declining estrogen increases osteoporosis risk. Vitamin D is critical for calcium absorption and bone health. Evidence links deficiency to higher fracture risk. However, evidence for non-skeletal benefits (e.g., mood, sleep) is weaker and mostly observational. Routine screening without specific risk factors is not universally recommended by guidelines. If deficiency is confirmed, supplementation is beneficial, but high doses without need can cause harm (hypercalcemia). Overall evidence is moderate: clear benefits for bone health, but insufficient support for universal prevention of all menopausal symptoms. Individual factors like sun exposure, diet, and bone density should guide decisions.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-e252051a01c2347a01d03505